Paper41649596
Unveiling the anti-glycation properties of acetylsalicylic acid: targeted inhibition of albumin glycation.
Tupe R and 2 others. Amino Acids, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Unveiling the anti-glycation properties of acetylsalicylic acid: targeted inhibition of albumin glycation. Papers, record 41649596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41649596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unveiling the anti-glycation properties of acetylsalicylic acid: targeted inhibition of albumin glycation.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspirin | Major topic |
| Serum Albumin | Major topic |
| Humans | |
| Glycosylation | |
| Antiglycation Agents | |
| Glycation End Products, Advanced | |
| Spectrometry, Fluorescence | |
| Glycated Serum Albumin |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9560197 | Protein-bound acrolein: potential markers for oxidative stress. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9560197 | PubMed |
| 2 | 34202801 | How Does Glycation Affect Binding Parameters of the Albumin-Gliclazide System in the Presence of Drugs Commonly Used in Diabetes? In Vitro Spectroscopic Study. | Molecules | 2021 | https://conductscience.org/library/papers/34202801 | PubMed |
| 3 | 6706980 | Nonenzymatic glycosylation of human serum albumin alters its conformation and function. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6706980 | PubMed |
| 4 | 8853285 | Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy. | Gen Pharmacol | 1996 | https://conductscience.org/library/papers/8853285 | PubMed |
| 5 | 37372968 | Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37372968 | PubMed |
| 6 | 32267079 | An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. | Diabetes Obes Metab | 2020 | https://conductscience.org/library/papers/32267079 | PubMed |
| 7 | 34143596 | Revealing Advanced Glycation End Products Associated Structural Changes in Serum Albumin. | ACS Biomater Sci Eng | 2021 | https://conductscience.org/library/papers/34143596 | PubMed |
| 8 | 36244155 | Effect of crocin on glycated human low-density lipoprotein: A protective and mechanistic approach. | Spectrochim Acta A Mol Biomol Spectrosc | 2023 | https://conductscience.org/library/papers/36244155 | PubMed |
| 9 | 38428781 | Alleviation of albumin glycation-induced diabetic cardiomyopathy by L-Arginine: Insights into Nrf-2 signaling. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38428781 | PubMed |
| 10 | 26471084 | Glycated Serum Albumin and AGE Receptors. | Adv Clin Chem | 2015 | https://conductscience.org/library/papers/26471084 | PubMed |
| 11 | 40423225 | Effect of Cilostazol and Aspirin During Hyperacute Stroke Phase in Rats: An Experimental Research Study. | Neurol Int | 2025 | https://conductscience.org/library/papers/40423225 | PubMed |
| 12 | 30986221 | Prevention of haemoglobin glycation by acetylsalicylic acid (ASA): A new view on old mechanism. | PLoS One | 2019 | https://conductscience.org/library/papers/30986221 | PubMed |
| 13 | 39488833 | Protocol for evaluating drug-protein interactions based on fluorescence spectroscopy. | STAR Protoc | 2024 | https://conductscience.org/library/papers/39488833 | PubMed |
| 14 | 1464241 | Glycation products and the pathogenesis of diabetic complications. | Diabetes Care | 1992 | https://conductscience.org/library/papers/1464241 | PubMed |
| 15 | 34326954 | Comprehensive overview of human serum albumin glycation in diabetes mellitus. | World J Diabetes | 2021 | https://conductscience.org/library/papers/34326954 | PubMed |
| 16 | 34883189 | IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. | Diabetes Res Clin Pract | 2022 | https://conductscience.org/library/papers/34883189 | PubMed |
| 17 | 13650640 | Tissue sulfhydryl groups. | Arch Biochem Biophys | 1959 | https://conductscience.org/library/papers/13650640 | PubMed |
| 18 | 8660627 | The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. | Anal Biochem | 1996 | https://conductscience.org/library/papers/8660627 | PubMed |
| 19 | 23841099 | High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23841099 | PubMed |
| 20 | 34481855 | Phytochemical thymoquinone prevents hemoglobin glycoxidation and protofibrils formation: A biophysical aspect. | Int J Biol Macromol | 2021 | https://conductscience.org/library/papers/34481855 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41649596
GET https://conductscience.org/api/papers/v1/41649596/references?page=2